Medical diagnostic tests developer Inova Diagnostics has introduced a rapid-response chemiluminescent analyser with Quanta Flash reagents for autoimmune disease diagnostic testing.

The Bio-Flash analyser, which uses chemiluminescent technology, is designed for use in clinical reference and hospital laboratories to provide full automation of a broad menu of highly accurate Quanta Flash immunoassays for autoimmunity testing.

Bio-Flash and the Quanta Flash reagents, which are classified as moderately complex under the Clinical Laboratories Improvements Act (CLIA), generate first result in as little as 30 minutes, with additional results produced at a rate of one-per-minute thereafter.

The analyser also offers other benefits including an increased analytical measuring range, onboard dilution and stored calibration.

A comprehensive menu of Quanta Flash reagents is also available, including tests to aid in the diagnosis of celiac disease, vasculitis, antiphospholipid syndrome and connective tissue diseases, according to the company.

Alberta Research and Innovation Authority chairman and University of Calgary professor of medicine and Arthritis Society Research chair Dr Marvin Fritzler said Bio-Flash has dramatically enhanced the workflow and decreased turnaround times for autoantibody testing at his laboratory.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"The user-friendly interface allows rapid adoption by laboratory staff members," Fritzler said.

"We are looking forward to an expanding catalogue of immunoassays developed by INOVA."